Regulatory affairs/ regulatory requirements for drug approval

Authors

Prajakta R. Patil
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India
Sachin S. Mali
Department of Pharmaceutics, Bharati Vidyapeeth college of Pharmacy, Kolhapur 416 013, India
Riya R. Patil
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India
Dhanashree R. Davare
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India

Synopsis

Introduction, Regulatory Affairs Historical Overview, Regulatory Authorities, Regulatory Affairs Department Role, and Regulatory Affairs Professionals' Responsibilities. Regulations needed to approve a drug: Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Pharmacology, Drug Metabolism and Toxicology, Non-Clinical Drug Development, Pharmacology, Investigational New Drug (IND) Application, Investigator's Brochure (IB) and New Drug Application (NDA), and Management of Clinical Studies.
Keywords: Drug Approval, Clinical Research, Investigational New Drug (IND), New Drug Application (NDA), Biostatistics

Published

5 February 2025

Categories

How to Cite

Patil, P. R. ., Mali, S. S. ., Patil, R. R. ., & Davare, D. R. . (2025). Regulatory affairs/ regulatory requirements for drug approval. In V. S. Joshi, S. S. . Mali, D. A. . Bhagwat, & P. V. . Chavan (Eds.), Technology and Quality in Industrial Pharmacy: Theory and Practice in Pharmaceutical Sciences (pp. 59-97). Deep Science Publishing. https://doi.org/10.70593/978-93-49307-31-5_3